Lysophosphatidylglycerol in Asthma Pathogenesis
NCT06327516 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2024-03-26
Summary
The study aims to investigate the relationship between the small molecule metabolite lysophosphatidylglycerol and asthma clinical features and explore its involvement in asthma pathogenesis.
Conditions
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Principal Investigators
-
Chun Chang · Peking University Third Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-01-01
- Primary Completion
- 2024-12-31
- Completion
- 2025-06-30
Countries
- China
Study Locations
More Related Trials
-
The Role of Biomarkers in the Occurrence and Development of Asthma
NCT05768399 ·Status: RECRUITING
-
The Effects of Montelukast on Smokers With Asthma
NCT00712335 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Clinical Study on the Clinical Efficacy and Prognostic Outcome of ICS/LABA Combined With Liqin Zhike Formula in the Treatment of Cough Variant Asthma
NCT07272278 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients
NCT01577082 ·Status: COMPLETED ·Phase: PHASE3
-
SAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Training
NCT04395937 ·Status: RECRUITING ·Phase: NA
-
Effect of Montelukast on Remodelling Markers in Asthmatic Children
NCT00875082 ·Status: COMPLETED ·Phase: PHASE4
-
GPIAG and Leicester Asthma and Dysfunctional Breathing (GLAD) Study: a Randomised Controlled Study
NCT00515840 ·Status: COMPLETED ·Phase: PHASE3
-
Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Provocation Test
NCT01759472 ·Status: UNKNOWN
-
Inflammatory Markers in Exhaled Breath Condensates From Asthmatic Patients
NCT01246414 ·Status: COMPLETED
-
Develop and Implement Asthma Controlling Strategies (1)
NCT00005732 ·Status: COMPLETED
-
Some Biomarkers in Bronchial Asthma in Children
NCT04175093 ·Status: UNKNOWN
-
Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.
NCT01581710 ·Status: COMPLETED ·Phase: NA
-
The Effect of Long Term Inhaled Corticosteroids on the Risk of Cardiovascular Morbidities
NCT00959257 ·Status: COMPLETED
-
Phenotyping Disease Severity in Asthma
NCT05078021 ·Status: RECRUITING
-
Change of Airway Hyperresponsiveness to Mannitol and Methacholine in Patients With Asthma
NCT01725360 ·Status: COMPLETED ·Phase: PHASE4
-
Develop and Implement Asthma Controlling Strategies (2)
NCT00005733 ·Status: COMPLETED
-
TNF Alpha in Refractory Asthma
NCT00276029 ·Status: COMPLETED ·Phase: NA
-
Inflammatory, Functional and Image Composite Measure to Define Asthma Control
NCT00597064 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans
NCT01514760 ·Status: COMPLETED ·Phase: NA
-
The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids in Asthma
NCT00792337 ·Status: COMPLETED ·Phase: PHASE3
-
Leukotriene D4 Bronchial Provocation Test (LTD4-BPT) as an Indicator for the Use of Leukotriene Receptor Antagonist (LTRA)
NCT01414868 ·Status: COMPLETED ·Phase: NA
-
Airway Microbiota Based Treatment of Asthma in Preschool Children
NCT04527016 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Relevance of Small Airways Disease in Severe Asthma Patients Treated With Anti-InterLeukin-5 Therapy
NCT05706597 ·Status: UNKNOWN
-
Safety, Tolerability, and Pharmacokinetics of PA9159 Inhalation Aerosol in Healthy Adult Subjects
NCT06916273 ·Status: COMPLETED ·Phase: PHASE1
-
Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma
NCT02124226 ·Status: UNKNOWN ·Phase: PHASE3